Degradable nanocatalyst enables antitumor/antibacterial therapy and promotion of wound healing for diabetes via self-enhanced cascading reaction

Diabetic patients often have problems such as residual tumor and wound infection after tumor resection, causing severe clinical problems. It is urgent to develop effective therapies to reach oncotherapy/anti-infection/promotion of wound healing combined treatment. Herein, we propose CS/MnO2-GOx (CMGOx) nanocatalysts for the specific catalytic generation of •OH to inhibit tumors and bacteria in a hyperglycemic environment. The good biocompatible chitosan (CS), as a carrier for the catalyst, exhibits excellent antibacterial effect as well as promotes wound healing. Glucose oxidase (GOx) is loaded on the surface of CS nanoparticles to generate H2O2 and gluconic acid by consuming glucose (starvation therapy, ST) and O2. The MnO2 depletes glutathione (GSH) to produce Mn2+, amplifying oxidative stress and further promoting the activity of Mn2+-mediated Fenton-like reaction to produce •OH (chemodynamic therapy, CDT) in weak acidic environment. Moreover, the produced gluconic acid lowers the pH of the environment, enhancing chemodynamic therapy (ECDT). The tumor cells and bacteria are efficiently eliminated by the synergistic effect of ST and ECDT. The MnO2 nanoparticles at neutral environment decomposes H2O2 into O2, which cooperate with CS to promote healing. The self-enhanced cascade reaction of CMGOx in situ exhibits excellent effects of antitumor/antibacterial therapy and promotion of wound healing, offering a promising integrated treatment for diabetic patients after tumor surgical resection. A degradable nanocatalyst-CMGOx based on chitosan utilizes endogenous substances for self-enhanced cascade catalytic reactions to achieve antitumor/antibacterial therapy and promotion of wound healing for diabetes via synergistic effect of chemodynamic therapy and starvation therapy. [Display omitted]